nilotinib
Generic: nilotinib
Labeler: cipla usa inc.Drug Facts
Product Profile
Brand Name
nilotinib
Generic Name
nilotinib
Labeler
cipla usa inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
nilotinib 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
69097-032
Product ID
69097-032_d748f03e-56ba-48e2-ae13-e8e74fac55e7
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA218922
Listing Expiration
2026-12-31
Marketing Start
2025-06-18
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69097032
Hyphenated Format
69097-032
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
nilotinib (source: ndc)
Generic Name
nilotinib (source: ndc)
Application Number
NDA218922 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 4 CARTON in 1 CARTON (69097-032-74) / 4 BLISTER PACK in 1 CARTON (69097-032-56) / 7 CAPSULE in 1 BLISTER PACK (69097-032-17)
- 4 CARTON in 1 CARTON (69097-032-91) / 2 BLISTER PACK in 1 CARTON (69097-032-73) / 14 CAPSULE in 1 BLISTER PACK (69097-032-76)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d748f03e-56ba-48e2-ae13-e8e74fac55e7", "openfda": {"nui": ["N0000175605", "N0000020009", "N0000187062", "N0000182137", "N0000187064", "N0000187063", "N0000191272", "N0000185503"], "unii": ["F41401512X"], "rxcui": ["2715459", "2715469", "2715473"], "spl_set_id": ["e27c3e09-bc4f-4f01-be05-1c43ac72285d"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "UGT1A1 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 CARTON in 1 CARTON (69097-032-74) / 4 BLISTER PACK in 1 CARTON (69097-032-56) / 7 CAPSULE in 1 BLISTER PACK (69097-032-17)", "package_ndc": "69097-032-74", "marketing_start_date": "20250618"}, {"sample": false, "description": "4 CARTON in 1 CARTON (69097-032-91) / 2 BLISTER PACK in 1 CARTON (69097-032-73) / 14 CAPSULE in 1 BLISTER PACK (69097-032-76)", "package_ndc": "69097-032-91", "marketing_start_date": "20250618"}], "brand_name": "Nilotinib", "product_id": "69097-032_d748f03e-56ba-48e2-ae13-e8e74fac55e7", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "69097-032", "generic_name": "Nilotinib", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nilotinib", "active_ingredients": [{"name": "NILOTINIB", "strength": "200 mg/1"}], "application_number": "NDA218922", "marketing_category": "NDA", "marketing_start_date": "20250618", "listing_expiration_date": "20261231"}